By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Selective phosphodiesterase-4 inhibitors > Daliresp
Selective phosphodiesterase-4 inhibitors

Daliresp

https://themeditary.com/drug/daliresp-1376.html
Medically Reviewed by Sanjai Sinha, MD TheMediTary.Com | Reviewed: Jul 13, 2023  Additional Content by TheMediTary.Com

Generic name: roflumilast [ roe-floo-mi-last ]

Drug class: Selective phosphodiesterase-4 inhibitors

Dosage form: tablet

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Roflumilast, Roflumilast (systemic) (monograph)

Contents
Uses Warnings Before Taking Dosage Side effects Interactions
  • Daliresp (Roflumilast [ roe-floo-mi-last ])-D 500-500 mcg-White-Round Daliresp 500 mcg (D 500)
  • Daliresp (Roflumilast [ roe-floo-mi-last ])-D 250-250 mcg-White-Round Daliresp 250 mcg (D 250)
  • View all images

What is Daliresp?

Daliresp reduces inflammation in the lungs that leads to COPD (chronic obstructive pulmonary disease).

Daliresp is used to prevent worsening of symptoms in people with severe COPD.

Daliresp is not a bronchodilator and will not treat a bronchospasm attack that has already begun.

Warnings

You should not use Daliresp if you have moderate or severe liver disease.

Some people have thoughts about suicide while taking Daliresp. Stay alert to changes in your mood or symptoms. Report any new or worsening symptoms to your doctor.

Tell your doctor about all your current medicines and any you start or stop using. Many drugs can interact, and some drugs should not be used together.

Call your doctor at once if you have rapid and unintended weight loss.

Before taking this medicine

You should not use Daliresp if you are allergic to roflumilast, or if you have moderate or severe liver disease.

To make sure Daliresp is safe for you, tell your doctor if you have ever had:

  • liver disease; or

  • depression, mental illness, or suicidal thoughts or actions.

Some people have thoughts about suicide while taking Daliresp. Your doctor should check your mood at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether roflumilast passes into breast milk or if it could affect the nursing baby. Tell your doctor if you are breast-feeding.

Do not give this medicine to a child without medical advice.

Daliresp pregnancy and breastfeeding warnings (more detail)

How should I take Daliresp

Take Daliresp exactly as prescribed by your doctor. Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.

Daliresp is usually taken once per day, with or without food. Follow your doctor's instructions.

Weight loss is a common side effect of roflumilast. While using this medicine, weigh yourself regularly and tell your doctor if you have any unplanned or unexplained weight loss.

Do not share this medicine with another person, even if they have the same symptoms you have.

Store at room temperature away from moisture and heat.

Dosing information

Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

To reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations: 500 mcg orally once a day, with or without food

Detailed Daliresp dosage information
Daliresp Dosage information (more detail)

Before Taking

You should not use Daliresp if you are allergic to roflumilast, or if you have moderate or severe liver disease.

To make sure Daliresp is safe for you, tell your doctor if you have ever had:

  • liver disease; or

  • depression, mental illness, or suicidal thoughts or actions.

Some people have thoughts about suicide while taking Daliresp. Your doctor should check your mood at regular visits. Your family or other caregivers should also be alert to changes in your mood or symptoms.

It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether roflumilast passes into breast milk or if it could affect the nursing baby. Tell your doctor if you are breast-feeding.

Do not give this medicine to a child without medical advice.

Daliresp pregnancy and breastfeeding warnings (more detail)

Related/similar drugs

prednisone, Symbicort, Breo Ellipta, Ventolin, Spiriva, Ventolin HFA, Anoro Ellipta

What happens if I miss a dose?

Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Daliresp?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Daliresp side effects

Get emergency medical help if you have signs of an allergic reaction to Daliresp: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Report any new or worsening symptoms to your doctor, such as: mood or behavior changes, anxiety, depression, trouble sleeping, or if you feel impulsive, or you have thoughts about suicide or hurting yourself.

Call your doctor at once if you have rapid and unintended weight loss.

  • rapid and unintended weight loss;

  • tremors;

  • pain or burning when you urinate;

Common Daliresp side effects may include:

  • nausea, diarrhea;

  • loss of appetite, minor weight loss;

  • headache, dizziness;

  • occasional sleep problems;

  • back pain; or

  • flu symptoms.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Daliresp Side Effects

What other drugs will affect Daliresp?

Many drugs can interact with roflumilast. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all your current medicines and any medicine you start or stop using.

More about Daliresp (Roflumilast [ roe-floo-mi-last ])

Dosage information
Daliresp Side Effects
During pregnancy
Daliresp Prescribing Information
Drug images
Side effects
Drug class: Selective phosphodiesterase-4 inhibitors

Related treatment guides

COPD
COPD, Maintenance
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by